Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram

Starting soon

Conditions studied: Arterial Hypertension, Heart Rhythm Disorders, Valvular Heart Diseases, Heart Failure, Diabetes Mellitus, Chronic Kidney Disease (Stage 3-4), Metabolic Syndrome, Coronary Artery Disease

In brief

It is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 4000 patients 18 years old and older in the training sample and 1000 patients over 18 years old in the test sample (the total number of patients is at least 5000 people). Patients will be included in the study if they have undergone a full examination (laboratory, clinical and instrumental), allowing for the verification or exclusion of cardiac and cardiac-associated pathology in accordance with current recommendations. During the course of the study, the authors of the work do not interfere with the above-mentioned scope of the examination, which is carried out on patients in accordance with clinical guidelines. All patients included in the study will undergo ECG recording in standard lead I for 1 minute twice, followed by spectral analysis of the obtained data, which will be stored at the remote monitoring center of Sechenov University without being linked to the personal data of patients. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform. The result of this study will be the identification of ECG parameters that will correlate with cardiac and cardiac-associated pathology

Key facts

Study ID

NCT07396792

Run by

I.M. Sechenov First Moscow State Medical University

People needed

4000

Starts

2026-04-01

Expected to finish

2028-05-13

Last updated by the study team

2026-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The presence of written informed consent of the patient to participate in the study
• Availability of examination data allowing for the verification or exclusion of cardiac and cardiac-associated pathology
• Age 18 years old and older
• Non-inclusion criteria:
• Patients with an implanted permanent pacemaker;
• ECG changes that prevent spectral analysis;
• Conditions that may impair the quality of the ECG recording (Parkinson's disease, essential tremor, etc.);
• Conditions that make ECG recording in lead I impossible (congenital anomalies of the upper limbs, traumatic amputation of the upper limbs).
• Lack of written informed consent from the patient to participate in the study.

You may not qualify if…

• Poor quality of the ECG recording on a single-channel ECG monitor
• Insufficient examination data to verify or exclude cardiac or cardiac-associated pathology;
• Patient's unwillingness to continue participating in the study for any reason.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.